[EN] COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED 2-AMINOIMIDAZOLES<br/>[FR] COMPOSITIONS ET PROCÉDÉS COMPRENANT DES 2-AMINOIMIDAZOLES SUBSTITUÉS
申请人:CURZA GLOBAL LLC
公开号:WO2018184019A1
公开(公告)日:2018-10-04
The present invention presents 2-(acylamino)imidazoles with therapeutic activity, including selective activity against cancer cells, and compositions comprising them. Methods of using and preparing the 2-(acylamino)imidazoles are also presented.
Acyl, N-protected .alpha.-aminoacyl, and peptidyl derivatives as prodrug forms of the alcohol deterrent agent cyanamide
作者:Chul Hoon Kwon、Herbert T. Nagasawa、Eugene G. DeMaster、Frances N. Shirota
DOI:10.1021/jm00160a021
日期:1986.10
were synthesized specifically as prodrugs, including benzoylcyanamide (2), pivaloylcyanamide (3), and 1-adamantoylcyanamide (4), as well as long- and medium-chain fatty acyl derivatives such as palmitoyl- (6), stearoyl- (7), and n-butyrylcyanamide (5). N-Protected alpha-aminoacyl and peptidyl derivatives of cyanamide were also synthesized, and these include N-carbobenzoxyglycyl- (10), hippuryl- (13)
[EN] A PROCESS FOR PREPARING 4-METHYL-4-IMIDAZOLIN-2-ONE AND DERIVATIVES THEREOF
申请人:PFIZER INC.
公开号:WO1986002070A1
公开(公告)日:1986-04-10
(EN) 4-Methyl-4-imidazolin-2-one, useful as a biotin intermediate, is prepared by reacting acetol and urea.(FR) Le 4-méthyl-4-imidazolin-2-one, utile en tant qu'intermédiaire de la biotine, est préparé en faisant réagir de l'acétol avec de l'urée.
The invention relates to inhibitors of Sphingosine Kinase enzymatic activity, and methods of treating diseases and disorders by administering inhibitors of Sphingosine Kinase enzymatic activity.